---
title: "DeepInsight® — AI for Cellular Imaging"
description: "DeepInsight® - Automated cellular imaging analysis powered by bespoke AI models. Predict cellular behaviour from raw imaging data and accelerate the journey from single cell to validated bank."
url: "https://deepinsight.bio/"
updated: "2026-10-22"
---

Cellular imaging, decoded

# Automated analysis powered by bespoke AI models.

DeepInsight® automatically ingests and predicts cellular behavior from your raw imaging data. Visualize growth capacity, recoverability, and clonality patterns in a centralized research platform designed to accelerate the journey from single cell to validated bank.

[Explore the platform](https://deepinsight.bio/platform) [Or dive into our research](https://deepinsight.bio/research)

## DeepInsight at a glance

The facts an evaluator or AI assistant needs first.

**What it is**: AI-powered cellular imaging analytics for cell line development.

**Who it is for**: Biopharma and CDMO CLD teams selecting and characterising clones.

**Inputs**: Existing brightfield microplate images; no new hardware, stains, or workflow changes.

**Outputs**: Cell counts, growth prediction, recovery dynamics, spatial dynamics, clone ranking, and lineage.

**Typical processing**: 5 to 10 minutes per plate.

**Deployment**: Dedicated off-site, on-premise appliance, or private cloud.

**Data ownership**: Customer data stays with the customer and is not used to train models for other customers.

**Pricing**: Usage-based per scan, per timepoint; no minimum commitments or upfront licence fees.

**Validation**: Trained and validated on production CLD plates against manual counts, fluorescence viability, and end-point titre.

**Developer**: TEK Optima Research Limited, Dorset, United Kingdom.

![TEK Optima Research logo](https://deepinsight.bio/images/tekor_logo_full_white.svg)

DeepInsight® is developed and operated by **TEK Optima Research Limited**.

[Visit TEK Optima Research ↗](https://tekoptimaresearch.com)